Related Experiment Video
Updated: Mar 13, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Sarcopenia in atrial fibrillation: a prospective study.
Mehmet Akif Topçuoğlu1, Ezgi Yilmaz1, Doğan Dinç Öge1
1Department of Neurology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.
Atrial fibrillation (AF) is linked to poorer muscle health, including reduced muscle strength and thickness. This suggests that managing AF should involve assessing muscle health and preventing malnutrition.
Area of Science:
- Cardiology
- Geriatrics
- Neurology
Background:
- The relationship between atrial fibrillation (AF) and lean body mass is not well understood.
- This study investigates the impact of AF on sarcopenia indicators and muscle architecture.
Purpose of the Study:
- To examine the effects of AF on various sarcopenia indices.
- To assess muscle architecture using ultrasonography in individuals with and without AF.
- To explore associations between AF, sarcopenia, and quality of life.
Main Methods:
- Compared 72 AF patients with 538 controls on sarcopenia indices (anthropometry, SPPB, HGS, BIA, SMMI, PhA).
- Utilized muscle ultrasonography to evaluate thickness, CSA, fL, and PeA of specific muscles (RF, BB, VL, VIM, GCM).
- Assessed malnutrition, sarcopenia consequences (fall, fatigue, SarQol), and screening (SARC-F) using multivariable linear models.
Main Results:
- AF patients had higher SARC-F and SarQol scores.
- AF was independently associated with lower hand grip strength, reduced phase angle, and decreased rectus femoris and quadriceps femoris muscle thickness.
- Muscle ultrasound parameters and BIA indices tended to be lower in individuals with AF.
Conclusions:
- Atrial fibrillation is associated with impaired muscle health and reduced quality of life.
- Thigh muscle ultrasound and malnutrition prevention strategies are recommended for AF management.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
